Comparação da midríase medicamentosa obtida em pacientes diabéticos tipo 2 sem neuropatia e não-diabéticos
Ano de defesa: | 2010 |
---|---|
Autor(a) principal: | |
Orientador(a): | |
Banca de defesa: | |
Tipo de documento: | Dissertação |
Tipo de acesso: | Acesso aberto |
Idioma: | por |
Instituição de defesa: |
Programa de Pós-graduação em Ciências Médicas
Ciências Médicas |
Programa de Pós-Graduação: |
Não Informado pela instituição
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: | |
Link de acesso: | https://app.uff.br/riuff/handle/1/19096 |
Resumo: | Purpose: Evaluate and compare obtained mydriasis with phenylephrine 10% associated with tropicamide 1%, in type 2 diabetics and non-diabetic patients. Methods: A total of 60 patients (120 eyes) scheduled for fundoscopy were dilated with phenylephrine 10% and tropicamide 1% (group 0, n=30 type 2 diabetic patients, 60 eyes and group 1, n=30 non-diabetic patients, 60 eyes). Only one drop per eye of each drug was administered. In both groups, pupil diameter was measured after 40 minutes of eyedrops instillation. Results: Mean age for the diabetic group was 62.27 years (SD = 8.61 years) and for the non-diabetic group was 56.57 years (SD = 17.28 years). There was no significant difference between both groups. (p = 0.18). Considering right eyes, mean pupil diameter was 8.47 mm in the diabetic group (SD = 0.86 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between both groups (p = 0.15). Considering left eyes, mean pupil diameter was 8.53 mm in the diabetic group (SD = 0.94 mm) and 8.77 mm (SD = 0.86 mm) in the non-diabetic group. There was no significant difference between the two groups (p = 0.32). Conclusion: When the combination of phenylephrine 10% and tropicamide 1% is used, type 2 diabetic patients can achieve mydriasis as satisfactory as non-diabetic patients, allowing adequate fundus examination and/or retinopathy treatment. |